Compugen Reports Fourth Quarter and Full Year 2020 Results
HOLON, Israel, Feb. 25, 2021 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the fourth quarter and full year ended December 31, 2020. “Our encouraging new data…